ALK-positive lung cancer represents a unique subtype of lung cancer driven by specific genetic alterations. Over the past decade, remarkable advances in precision medicine and targeted therapies have transformed the treatment landscape, offering patients longer survival, improved quality of life, and renewed hope.

In Win the ALK-Positive Lung Cancer Fight, Dr. Preetam Jain explains the science behind ALK-positive lung cancer in a simple and patient-friendly manner. The book explores how molecular testing helps identify actionable genetic mutations and how modern targeted therapies can effectively control tumour growth while minimizing treatment-related side effects.